Genenta Science S.p.A. Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
Genenta Science S.p.A. (GNTA) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price of 2.32 EUR/shares for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-01.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice · last filed 2026-04-01
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 0 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 12 month |
|---|---|---|---|
| 2025-12-31 | 2.32 EUR/shares 20-F · filed 2026-04-01 | ||
| 2025-06-30 | 3.83 EUR/shares 6-K · filed 2025-10-10 | ||
| 2024-12-31 | 2.87 EUR/shares 20-F · filed 2026-04-01 | ||
| 2023-12-31 | 5.30 EUR/shares 20-F · filed 2026-04-01 | ||
| 2023-06-30 | 5.30 EUR/shares 6-K · filed 2023-10-20 | ||
| 2022-12-31 | 4.99 EUR/shares 20-F · filed 2025-03-28 | ||
| 2022-06-30 | 1.00 EUR/shares 6-K · filed 2022-10-25 | ||
| 2022-04-26 | 6.38 EUR/shares 6-K · filed 2022-10-25 | ||
| 2021-12-31 | 1.00 EUR/shares 20-F · filed 2024-03-29 |